As of November 7, 2026, Starling Oncology, Inc. is a publicly traded company (Nasdaq: STLN). The largest insider holding is Jorey Chernett, a 10% owner, with 10,660,858 shares (10.5% of shares outstanding), per Form 4 of August 17, 2026. No bankruptcy or receivership appears in its SEC Form 8-K filings. Founder or officer holdings: Jorey Chernett, a 10% owner (10.2%, reporting on Schedule 13G) (Schedule 13G/A, March 16, 2026).
Is this your company?
About to sign with, pay or invest in Starling Oncology, Inc.? See the free Snapshot first.
Free to see. No signup.
Is Starling Oncology, Inc. a real, registered company?
- Oncology Institute, Inc. files with the SEC under CIK 1799191 (its SEC filings).
- Its shares are listed under the ticker STLN on Nasdaq (also STLNW, DFPH) (SEC company record).
- Incorporated in Delaware; business address in Cerritos, California, as its SEC filings state.
- Court and bankruptcy records: see Before you sign or pay below.
Before you sign or pay
- Court and bankruptcy: No federal court case or bankruptcy filing found under Oncology Institute, Inc. in our court records and SEC 8-K records (as of 2026-11-07).
- Leadership changes: the latest reported is Brad Hively (Form 8-K filed 2026-09-02). Check you are dealing with the people now in charge.
- Ownership: 5%+ holders are reported on Schedule 13D or 13G; the latest names Chernett Jorey (filed 2026-03-16).
Who are Starling Oncology, Inc.'s owners and officers?
Starling Oncology, Inc.: incorporated in Delaware; business address in Cerritos, California; industry Services-Offices & Clinics of Doctors of Medicine (Form D, 2026-09-02).
Officers and directors, each with the role and the filing that names them:
- : Executive Officer, Director (Form D, 2025-04-08)
- : Executive Officer (Form D, 2025-04-08)
- : Executive Officer (Form D, 2025-04-08)
- : Executive Officer (Form D, 2025-04-08)
- : Director (Form D, 2025-04-08)
- : Director (Form D, 2025-04-08)
- : Director (Form D, 2025-04-08)
- : Director (Form D, 2025-04-08)
- : Director (Form D, 2025-04-08)
- : Director (Form D, 2025-04-08)
- : Director (Form D, 2025-04-08)
| Report | Holder | Share |
|---|---|---|
| Schedule 13D/A, 2026-05-15 | M33 Growth I L.P. | 4.94% |
| Schedule 13G/A, 2026-03-16 | Chernett Jorey | 10.2% |
| Schedule 13G, 2026-01-15 | Chernett Jorey | 5.2% |
| Schedule 13D/A, 2025-11-20 | M33 Growth I LP | 5.46% |
| Schedule 13D/A, 2025-09-05 | M33 Growth I LP | 9.79% |
Questions about who owns Starling Oncology, Inc.
Who owns Starling Oncology, Inc.?
On this page, 2 holders' latest ownership filings report 5% or more of Starling Oncology, Inc.: Chernett Jorey (10.2%, Schedule 13G/A, filed 2026-03-16) and M33 Growth I LP (5.46%, Schedule 13D/A, filed 2025-11-20).
Who are the largest shareholders of Starling Oncology, Inc.?
By the share each holder's latest filing reports, the largest holders of Starling Oncology, Inc. on this page are Chernett Jorey (10.2%) and M33 Growth I LP (5.46%).
When did Chernett Jorey buy into Starling Oncology, Inc.?
The filings give report dates, not purchase dates. The earliest filing from Chernett Jorey on this page is the Schedule 13G, filed 2026-01-15, reporting 5.2%; its latest, Schedule 13G/A filed 2026-03-16, reports 10.2%.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 5 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Want the whole picture on Starling Oncology, Inc.?
Example from a real report (our sample on Target): “Target eliminated approximately 1,800 corporate positions, with around 1,000 employees receiving layoff notices and the remainder accounted for by eliminating open roles.” Source: NBC News
A Full Report on Starling Oncology, Inc.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Starling Oncology, Inc. covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
11 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
| Filed | Person | Role | Change | Effective |
|---|---|---|---|---|
| Form 8-K, 2026-09-02 | Brad Hively | departed |
Which insiders own Starling Oncology, Inc. shares?
Directors, officers and holders of 10% or more report their shares on Forms 3, 4 and 5. Each line is the latest such report, largest holding first.
- , a 10% owner: 10,660,858 shares (10.5% of shares outstanding) (Form 4, 2026-08-17).
- , LLC, a director: 5,444,207 shares (5.3% of shares outstanding), on a joint filing (Form 4, 2025-11-20).
- M33 Growth I GP LLC, a director: 5,444,207 shares (5.3% of shares outstanding), on a joint filing (Form 4, 2025-11-20).
- M33 Growth I L.P., a director: 5,444,207 shares (5.3% of shares outstanding), on a joint filing (Form 4, 2025-11-20).
- , a director: 2,635,881 shares (2.6% of shares outstanding), held indirectly through By LLC (Form 4, 2025-07-28).
Shares outstanding: 101,991,024 as of 2026-11-03, from the company's latest SEC cover page.
How much has Starling Oncology, Inc. raised?
| Filed | Sold | Offered |
|---|---|---|
| Form D, 2025-04-08 | $16.44M | $16.44M |
Keep reading
More on Starling Oncology, Inc. and the records around it.
Starling Oncology, Inc. elsewhere on the record
- 5%+ stake filings May 2026
- Form D filing Apr 2025
Companies that share a holder
- Chernett Jorey also filed stake reports on 16 other companies: CVRx, Inc. (Oct 2026), WW INTERNATIONAL, INC. (Aug 2026), Neuronetics, Inc. (Aug 2026)
Related pages
Filings, cases and notices link to their records. A not-found line names the records searched; it is not proof of absence.
Not for employment, credit, insurance or tenancy decisions.
Cite this page
https://mentionfox.com/who-owns/oncology-institute